EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Preclinical Models of Oropouche Virus Infection and Disease

Daniel Morley iD, Emma Kennedy iD, Stuart Dowall

Pathogens · 11.12.2025 · 14 (12) · 1272

DOI: 10.3390/pathogens14121272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 11.12.2025. Verfasst von Daniel Morley und 2 weiteren Autor:innen. Beteiligte Einrichtung: UK Health Security Agency, Porton Down, Wiltshire SP4 0JG, UK. Hauptthemen laut MEDLINE: Bunyaviridae Infections, Disease Models, Animal, Orthobunyavirus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health and Social Care, Department of Health and Social Care using UK International Development funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oropouche virus (OROV) is an emerging and underreported arbovirus with dengue-like symptoms confounding diagnosis. OROV is also neuroinvasive, with a small number of cases presenting severe neurological symptoms. There have been recently reported deaths from confirmed cases of OROV and reported instances of vertical transmission from mother to foetus, with confirmed cases in Brazil and a congenital anomaly, reportedly as a consequence of OROV infection in Cuba, with further cases under investigation. Whilst cases of OROV infection occur mainly in South America, many cases have been imported elsewhere, including the United States and Europe. Despite the emerging threat to public health, animal modelling to study OROV pathogenicity and immunity and to evaluate therapeutic candidates remains limited. For this review, we carried out a literature search through major research databases (PubMed and Scopus) up to September 2025 to capture the extent of in vivo model development for this pathogen. We identified only 17 relevant primary research articles within these criteria which detailed hamster, mouse and non-human primate (NHP) models. Here, we discuss the extent of in vivo model development for OROV. In summary, small and large animal models need to be assessed with recent clinical isolates and reassortants, asymptomatic disease presentation in the NHP model requires further study and the hamster model shows potential for use in pathogenicity and vaccine or antiviral efficacy studies. We also compile relevant metadata and discuss the need for an animal model that more closely resembles human disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bunyaviridae InfectionsDisease Models, AnimalOrthobunyavirusAnimalsHumansMiceCricetinae

Stichwörter der Autor:innen

arbovirushamstermodelmousenon-human primateoropouchepreclinical

Autor:innen und Institutionen

  • UK Health Security Agency, Porton Down, Wiltshire SP4 0JG, UK.

ORCID-Profile: Daniel Morley, Emma Kennedy

Förderung

  • Department of Health and Social Care
  • Department of Health and Social Care using UK International Development funding

Zitieren

APA

Morley, D., Kennedy, E., & Dowall, S. (2025). Preclinical Models of Oropouche Virus Infection and Disease. Pathogens, 14(12), 1272. https://doi.org/10.3390/pathogens14121272

Vancouver

Morley D, Kennedy E, Dowall S. Preclinical Models of Oropouche Virus Infection and Disease. Pathogens. 2025;14(12):1272. doi:10.3390/pathogens14121272

BibTeX
@article{Morley2025,
  author = {Morley, Daniel and Kennedy, Emma and Dowall, Stuart},
  title = {Preclinical Models of Oropouche Virus Infection and Disease},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {1272},
  doi = {10.3390/pathogens14121272}
}
Kostenlos starten →